Ajinomoto Co. Inc. Acquires Cambrooke Therapeutics, Inc.

09:00 EST 10 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Cambrooke Therapeutics, Inc. (Cambrooke), a global leader and innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, today announced it has been acquired by Ajinomoto Co. Inc. (Ajinomoto),...

Other Sources for this Article

Cambrooke Therapeutics, Inc.
Elayna Rucker, 301-980-6594


More From BioPortfolio on "Ajinomoto Co. Inc. Acquires Cambrooke Therapeutics, Inc."

Quick Search


Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...